FDA combination product hearing
Executive Summary
FDA will hold a public hearing Nov. 25 to discuss the assignment, premarket review and postmarket regulation of combination products. The meeting will be at the DoubleTree Hotel in Rockville, Md. Event will have broader scope than June 24 hearing, which addressed jurisdiction for wound healing products with live cellular components (1"The Pink Sheet" July 1, p. 15)...